Disease Progression in Charcot‐Marie‐Tooth Disease Type <scp>4B</scp> (<scp>CMT4B</scp>) Associated With Mutations in Myotubularin‐Related Proteins 2 and 13

This international collective effort enabled collection of relevant data for characterizing natural history and estimating disease progression of CMT4B1/CMT4B2 ultrarare diseases, aiming at improving their management and paving the way for designing future clinical trials.

Authors

Institutions

Publication Details

Journal
European Journal of Neurology
Published
2025-02-01
DOI
https://doi.org/10.1111/ene.70084
Citations
1
Primary Topic
Hereditary Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disease Progression in Charcot‐Marie‐Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin‐Related Proteins 2 and 13

Arman Çakar, Alessandra Bolino, Alessandro Bertini, Stefano Tozza et al.
1 citations
European Journal of Neurology
Hereditary Neurological Disorders
0.91
article

Disease Progression in Charcot‐Marie‐Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin‐Related Proteins 2 and 13

Arman Çakar, Alessandra Bolino, Alessandro Bertini, Stefano Tozza, Steven S. Scherer, Mounia Bellatache, Stefano Carlo Previtali, Chiara Pisciotta, Paola Valentino, Tanya Stojkovic, Nicole Kressin, Mary M. Reilly, Mario Sabatelli, Michael E. Shy, Marco Luigetti, Sonia Nouioua, Rita Horváth, Mériem Tazir, Kevin R. Ward, Davide Pareyson, Matilde Laurá, Antonio Gambardella, Esra Battaloğlu, Alberto A. Zambon, Sabrina Sacconi, Shahram Attarian, Richard A. Lewis, Fiore Manganelli, David N. Herrmann, Julian Blake, Yeşim Parman
article en
1 citations

Abstract

This international collective effort enabled collection of relevant data for characterizing natural history and estimating disease progression of CMT4B1/CMT4B2 ultrarare diseases, aiming at improving their management and paving the way for designing future clinical trials.

European Journal of NeurologyVol. 32(2)
Università Cattolica del Sacro Cuore (IT), Cedars-Sinai Medical Center (US), Vita-Salute San Raffaele University (IT), University of Algiers Benyoucef Benkhedda (DZ), Université Côte d'Azur (FR), Aix-Marseille Université (FR), University of Cambridge (GB), Norfolk and Norwich University Hospital (GB), University of Iowa Hospitals and Clinics (US), Agostino Gemelli University Polyclinic (IT), Centre Hospitalier Universitaire de Nice (FR), Magna Graecia University (IT), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Centro Clinico Nemo (IT), IRCCS Ospedale San Raffaele (IT), National Hospital for Neurology and Neurosurgery (GB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), Boğaziçi University (TR), University College London (GB), University of Rochester (US), Istanbul University (TR), University of Naples Federico II (IT), University of Pennsylvania (US)
Charcot-Marie-Tooth Association, Sanofi, Muscular Dystrophy Association, Biogen, Alnylam Pharmaceuticals, Rare Diseases Clinical Research Network, Ministero della Salute, National Center for Advancing Translational Sciences
Openalex Percentile: Top 31%
Hereditary Neurological Disorders
0.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.